-
1.SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS 失效
标题翻译: 替代物4-BIALLBUTYR-ODER 5-BIARYLPENTASÄURENUND DERIVATE ALS MATRIX METALLOPROTEASE INHIBITOREN公开(公告)号:EP0790974B1
公开(公告)日:2002-08-14
申请号:EP95940572.1
申请日:1995-11-09
申请人: Bayer Corporation
发明人: KLUENDER, Harold, Clinton, Eugene , BENZ, Guenter, Hans, Heinz, Herbert , BRITTELLI, David, Ross , BULLOCK, William, Harrison , COMBS, Kerry, Jeanne , DIXON, Brian, Richard , SCHNEIDER, Stephan , WOOD, Jill, Elizabeth , VANZANDT, Michael, Christopher , WOLANIN, Donald, John , WILHELM, Scott, M.
IPC分类号: C07C59/88 , A61K31/19 , C07D213/00 , C07C59/48 , C07C59/68 , C07C59/90 , C07D333/00 , C07D241/00 , C07D275/00 , C07D207/00
CPC分类号: C07D207/08 , A61K31/4035 , A61K31/47 , C07C17/12 , C07C17/16 , C07C17/208 , C07C22/04 , C07C25/18 , C07C45/28 , C07C45/46 , C07C45/56 , C07C45/72 , C07C47/228 , C07C47/277 , C07C49/813 , C07C55/02 , C07C59/56 , C07C59/84 , C07C59/88 , C07C59/90 , C07C59/92 , C07C61/04 , C07C61/06 , C07C62/22 , C07C62/38 , C07C63/72 , C07C65/24 , C07C65/34 , C07C69/616 , C07C69/712 , C07C69/738 , C07C69/757 , C07C205/34 , C07C205/56 , C07C229/34 , C07C229/40 , C07C233/54 , C07C235/84 , C07C255/21 , C07C255/57 , C07C271/22 , C07C271/26 , C07C271/28 , C07C271/58 , C07C317/44 , C07C323/52 , C07C323/61 , C07C323/62 , C07C327/32 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D207/16 , C07D207/404 , C07D209/48 , C07D209/68 , C07D213/30 , C07D213/50 , C07D213/70 , C07D215/36 , C07D221/14 , C07D257/04 , C07D263/32 , C07D277/30 , C07D277/74 , C07D295/192 , C07D307/28 , C07D307/32 , C07D307/33 , C07D307/54 , C07D307/68 , C07D307/93 , C07D307/935 , C07D311/96 , C07D317/30 , C07D317/60 , C07D333/22 , C07D333/28 , C07D333/34 , C07D405/06 , C07D409/12 , C07D413/06 , C07D471/04 , C07D491/04 , C07F9/1415 , C07F9/4059
-
2.SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS 失效
标题翻译: 替代物4-BIALLBUTYR-ODER 5-BIARYLPENTABSÄURENUND DERIVATE ALS MATRIX METALLOPROTEASE INHIBITOREN公开(公告)号:EP0790974A1
公开(公告)日:1997-08-27
申请号:EP95940572.0
申请日:1995-11-09
申请人: Bayer Corporation
发明人: KLUENDER, Harold, Clinton, Eugene , BENZ, Guenter, Hans, Heinz, Herbert , BRITTELLI, David, Ross , BULLOCK, William, Harrison , COMBS, Kerry, Jeanne , DIXON, Brian, Richard , SCHNEIDER, Stephan , WOOD, Jill, Elizabeth , VANZANDT, Michael, Christopher , WOLANIN, Donald, John , WILHELM, Scott, M.
IPC分类号: A61K31 , A61P35 , A61P43 , C07C17 , C07C22 , C07C25 , C07C45 , C07C47 , C07C49 , C07C55 , C07C57 , C07C59 , C07C61 , C07C62 , C07C63 , C07C65 , C07C69 , C07C205 , C07C229 , C07C233 , C07C235 , C07C255 , C07C271 , C07C317 , C07C323 , C07C327 , C07D207 , C07D209 , C07D213 , C07D215 , C07D221 , C07D257 , C07D263 , C07D277 , C07D295 , C07D307 , C07D311 , C07D317 , C07D333 , C07D405 , C07D409 , C07D413 , C07D471 , C07D491 , C07D498 , C07F9
CPC分类号: C07D207/08 , A61K31/4035 , A61K31/47 , C07C17/12 , C07C17/16 , C07C17/208 , C07C22/04 , C07C25/18 , C07C45/28 , C07C45/46 , C07C45/56 , C07C45/72 , C07C47/228 , C07C47/277 , C07C49/813 , C07C55/02 , C07C59/56 , C07C59/84 , C07C59/88 , C07C59/90 , C07C59/92 , C07C61/04 , C07C61/06 , C07C62/22 , C07C62/38 , C07C63/72 , C07C65/24 , C07C65/34 , C07C69/616 , C07C69/712 , C07C69/738 , C07C69/757 , C07C205/34 , C07C205/56 , C07C229/34 , C07C229/40 , C07C233/54 , C07C235/84 , C07C255/21 , C07C255/57 , C07C271/22 , C07C271/26 , C07C271/28 , C07C271/58 , C07C317/44 , C07C323/52 , C07C323/61 , C07C323/62 , C07C327/32 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D207/16 , C07D207/404 , C07D209/48 , C07D209/68 , C07D213/30 , C07D213/50 , C07D213/70 , C07D215/36 , C07D221/14 , C07D257/04 , C07D263/32 , C07D277/30 , C07D277/74 , C07D295/192 , C07D307/28 , C07D307/32 , C07D307/33 , C07D307/54 , C07D307/68 , C07D307/93 , C07D307/935 , C07D311/96 , C07D317/30 , C07D317/60 , C07D333/22 , C07D333/28 , C07D333/34 , C07D405/06 , C07D409/12 , C07D413/06 , C07D471/04 , C07D491/04 , C07F9/1415 , C07F9/4059
摘要: Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula (T)xA-B-D-E-G, wherein A and B are aryl or heteroaryl rings; each T is a substituent group; x is 0, 1, or 2; the group D represents (a), (b), (c), (d), or (e); the group E represents a two or three carbon chain bearing one to three substituent groups which are independent or are involved in ring formation, possible structures being shown in the text and claims; and the group G represents -PO3H2, -M, (f), (g), or (h), in which M represents -CO2H, -CON(R11)2, or -CO2R?12; and R13¿ represents any of the side chains of the 19 noncyclic naturally occurring amino acids, and include pharmaceutically acceptable salts thereof.
摘要翻译: 用于基质金属蛋白酶的抑制剂,含有它们的药物组合物,以及用于治疗各种生理条件的方法。 目前要求保护的化合物具有其中每个T代表取代基的广义化学式“IMAGE”; x是0,1或2; D表示
delta为0或1; U'表示O,S或N,条件是当U'为N时,则δ= 0,当U'为O或S时,则δ= 1; R14是各种取代基中的任何一种; 并且G表示M,其中M表示-CO 2 H,-CON(R 11)2或-CO 2 R 12,R 11表示H或烷基,R 12表示烷基,R 13表示任何侧链的M, 19种非环状天然存在的氨基酸; 及其药学上可接受的盐。
-